Why BioAffinity Technologies Stock Is Popping Off
Why BioAffinity Technologies Stock Is Popping Off
BioAffinity Technologies Inc (NASDAQ:BIAF) shares are trading higher by 80.18% to $3.82 during Wednesday's trading session after the company announced it received an additional $7.7 million from the exercise of warrants.
What Else?
BioAffinity Technologies says the company intends to use the proceeds from the offering to expand existing operations and the commercialization of CyPathLung, a noninvasive test for the early detection of lung cancer which uses flow cytometry to count and characterize cells in a person's sputum, or phlegm.
Proceeds may also be used in the company's pursuit of regulatory approvals and research and development of additional diagnostics, cancer therapeutics, and for working capital and general corporate purposes.
See Also: So What's Happening With Ocugen Stock Today?
According to data from Benzinga Pro, BioAffinity Technologies has a 52-week high of $15.55 and a 52-week low of $2.02.
BioAffinity Technologies Inc (NASDAQ:BIAF) shares are trading higher by 80.18% to $3.82 during Wednesday's trading session after the company announced it received an additional $7.7 million from the exercise of warrants.
生物亲和力技术公司 纳斯达克股票代码:BIAF)的股价在周三的交易时段上涨了80.18%,至3.82美元,此前该公司宣布从行使认股权证中额外获得770万美元。
What Else?
还有什么?
BioAffinity Technologies says the company intends to use the proceeds from the offering to expand existing operations and the commercialization of CyPathLung, a noninvasive test for the early detection of lung cancer which uses flow cytometry to count and characterize cells in a person's sputum, or phlegm.
BioAffinity Technologies表示,该公司打算将此次发行的收益用于扩大CyPath的现有业务和商业化肺部,一种用于早期发现肺癌的非侵入性检测,它使用流式细胞术对人的痰液或痰液中的细胞进行计数和表征。
Proceeds may also be used in the company's pursuit of regulatory approvals and research and development of additional diagnostics, cancer therapeutics, and for working capital and general corporate purposes.
所得款项还可用于公司寻求监管部门的批准以及其他诊断方法、癌症疗法的研发,以及用于营运资金和一般公司用途。
See Also: So What's Happening With Ocugen Stock Today?
另见:那么今天的Ocugen股票发生了什么?
According to data from Benzinga Pro, BioAffinity Technologies has a 52-week high of $15.55 and a 52-week low of $2.02.
根据Benzinga Pro的数据,BioAffinity Technologies创下52周高点15.55美元,创52周低点2.02美元。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧